Related Experiment Video
Updated: Aug 16, 2026

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
Published on: May 19, 2020
Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae
Mitsuo Narita1, Hiroshi Tanaka, Takehiro Togashi
1Department of Pediatrics, Sapporo Tetsudo (JR) Hospital, Sapporo, Japan.
Abstract:
Mycoplasma pneumoniae sometimes causes central nervous system manifestations, which may involve the host immune response, as the organism does not directly damage neural cells, or release toxins. Therefore we measured the levels of interleukin-6, interleukin-8, interleukin-18, interferon-gamma, tumor necrosis factor-alpha, and transforming growth factor-beta1 in serum and cerebrospinal fluid samples from patients who manifested central nervous system manifestations during acute M. pneumoniae infection. The subjects were nine patients with early-onset encephalitis (central nervous system disease onset within 7 days from the onset of fever), four with late-onset encephalitis (onset at 8 days or later), three with encephalitis but without fever, and three with aseptic meningitis. Intrathecal elevations of interleukin-6 and interleukin-8 in all four types of central nervous system manifestations, and of interleukin-18 in late-onset encephalitis were observed. None of the cerebrospinal fluid samples contained detectable levels of interferon-gamma, tumor necrosis factor-alpha, or transforming growth factor-beta1. In conclusion, interleukin-6, interleukin-8, and interleukin-18 might be involved in the inflammatory process leading to the central nervous system manifestations caused by M. pneumoniae.
Insights
Mycoplasma pneumoniae infections can affect the central nervous system via immune responses. Elevated levels of interleukin-6, interleukin-8, and interleukin-18 in cerebrospinal fluid suggest their involvement in these neurological manifestations.
Area of Science:
- Neuroimmunology
- Infectious Diseases
- Molecular Biology
Background:
- Mycoplasma pneumoniae can cause central nervous system (CNS) manifestations.
- The exact mechanism involves the host immune response rather than direct neural damage or toxins.
- Understanding the inflammatory markers is crucial for diagnosing and managing these neurological complications.
Purpose of the Study:
- To measure serum and cerebrospinal fluid (CSF) levels of specific cytokines in patients with M. pneumoniae-associated CNS manifestations.
- To investigate the role of interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-18 (IL-18), interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and transforming growth factor-beta1 (TGF-β1) in the pathogenesis.
- To differentiate the cytokine profiles across various CNS manifestation types.
Main Methods:
- Analysis of serum and CSF samples from patients diagnosed with M. pneumoniae infection and CNS manifestations.
- Categorization of patients into early-onset encephalitis, late-onset encephalitis, encephalitis without fever, and aseptic meningitis groups.
- Quantification of cytokine levels using appropriate laboratory assays.
Main Results:
- Intrathecal elevations of IL-6 and IL-8 were detected in all four types of CNS manifestations.
- Elevated IL-18 levels were specifically observed in patients with late-onset encephalitis.
- IFN-γ, TNF-α, and TGF-β1 were not detectable in any of the CSF samples.
Conclusions:
- IL-6, IL-8, and IL-18 are implicated in the inflammatory processes underlying CNS manifestations of M. pneumoniae infection.
- These cytokines may serve as potential biomarkers for diagnosing and understanding the neuroinflammatory response.
- The findings highlight the role of specific immune mediators in M. pneumoniae-induced neurological disease.
Related Concept Videos
Bacterial Meningitis
Atypical Pneumonia
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Bacterial Meningitis I: Introduction
Cryptococcal Meningitis